Works matching IS 00071048 AND DT 2017 AND VI 177 AND IP 3
Results: 24
Measurement of BCR- ABL1 by RT- qPCR in chronic myeloid leukaemia: findings from an International EQA Programme.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 414, doi. 10.1111/bjh.14557
- By:
- Publication type:
- Article
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 457, doi. 10.1111/bjh.14570
- By:
- Publication type:
- Article
Cryptic 5q deletion in a patient with myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 347, doi. 10.1111/bjh.14590
- By:
- Publication type:
- Article
Immunotherapy for infectious diseases in haematological immunocompromise.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 348, doi. 10.1111/bjh.14595
- By:
- Publication type:
- Article
Granulocyte transfusions in the management of invasive fungal infections.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 357, doi. 10.1111/bjh.14597
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 333, doi. 10.1111/bjh.14356
- Publication type:
- Article
Diagnostic value of whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 395, doi. 10.1111/bjh.14545
- By:
- Publication type:
- Article
Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 404, doi. 10.1111/bjh.14549
- By:
- Publication type:
- Article
Changes in autonomic nervous activity during vaso-occlusive crisis in patients with sickle cell anaemia.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 484, doi. 10.1111/bjh.14064
- By:
- Publication type:
- Article
Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 486, doi. 10.1111/bjh.14066
- By:
- Publication type:
- Article
The cationic small molecule GW4869 is cytotoxic to high phosphatidylserine-expressing myeloma cells.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 423, doi. 10.1111/bjh.14561
- By:
- Publication type:
- Article
Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 441, doi. 10.1111/bjh.14562
- By:
- Publication type:
- Article
Thrombopoetin receptor agonist therapy in thrombocytopenia: ITP and beyond.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 475, doi. 10.1111/bjh.14564
- By:
- Publication type:
- Article
The six-minute walk test is a valuable measure of functional change following chemotherapy for AL (light-chain) cardiac amyloidosis.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 481, doi. 10.1111/bjh.14585
- By:
- Publication type:
- Article
Conditioning regimens for autologous haematopoietic stem cell transplantation - can natural killer cell therapy help?
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Bone marrow erythrophagocytosis and reticulocytopenia in autoimmune haemolytic anaemia.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 346, doi. 10.1111/bjh.14568
- By:
- Publication type:
- Article
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study ( ADVL1114).
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 467, doi. 10.1111/bjh.14569
- By:
- Publication type:
- Article
MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 492, doi. 10.1111/bjh.14080
- By:
- Publication type:
- Article
Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapse.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 495, doi. 10.1111/bjh.14086
- By:
- Publication type:
- Article
Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 449, doi. 10.1111/bjh.14567
- By:
- Publication type:
- Article
The six-minute walk test in patients with AL amyloidosis: a single centre case series.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 388, doi. 10.1111/bjh.14586
- By:
- Publication type:
- Article
Prognosis and risk assessment in AL amyloidosis - There and back again.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Announcements: MEETINGS AND CONFERENCES - Forthcoming Event.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 498, doi. 10.1111/bjh.14722
- Publication type:
- Article
Iron chelation therapy in low risk myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 375, doi. 10.1111/bjh.14602
- By:
- Publication type:
- Article